AU2007224668A1 - Substance for the treatment of tinnitus - Google Patents

Substance for the treatment of tinnitus Download PDF

Info

Publication number
AU2007224668A1
AU2007224668A1 AU2007224668A AU2007224668A AU2007224668A1 AU 2007224668 A1 AU2007224668 A1 AU 2007224668A1 AU 2007224668 A AU2007224668 A AU 2007224668A AU 2007224668 A AU2007224668 A AU 2007224668A AU 2007224668 A1 AU2007224668 A1 AU 2007224668A1
Authority
AU
Australia
Prior art keywords
vitamin
magnesium
tinnitus
blueberry extract
dosage unit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2007224668A
Other languages
English (en)
Inventor
Uwe Stoldt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2007224668A1 publication Critical patent/AU2007224668A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Packages (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2007224668A 2006-03-15 2007-03-15 Substance for the treatment of tinnitus Abandoned AU2007224668A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102006011922.3 2006-03-15
DE102006011922A DE102006011922A1 (de) 2006-03-15 2006-03-15 Mittel zur Behandlung von Tinnitus
PCT/EP2007/002294 WO2007104566A1 (de) 2006-03-15 2007-03-15 Mittel zur behandlung von tinnitus

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2013224648 Division 2007-03-15

Publications (1)

Publication Number Publication Date
AU2007224668A1 true AU2007224668A1 (en) 2007-09-20

Family

ID=38229816

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2007224668A Abandoned AU2007224668A1 (en) 2006-03-15 2007-03-15 Substance for the treatment of tinnitus

Country Status (9)

Country Link
US (2) US20090220592A1 (enExample)
EP (1) EP1993578A1 (enExample)
JP (1) JP2009529559A (enExample)
AU (1) AU2007224668A1 (enExample)
CA (1) CA2646528A1 (enExample)
DE (1) DE102006011922A1 (enExample)
EA (1) EA013457B1 (enExample)
IL (1) IL194066A0 (enExample)
WO (1) WO2007104566A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201010691A (en) * 2008-06-12 2010-03-16 Merz Pharma Gmbh & Co Kgaa 1-amino-alkylcyclohexane derivatives for the treatment of sleep disorders
JP2021519344A (ja) * 2018-03-23 2021-08-10 ヴァネッサ リサーチ インコーポレイテッドＶａｎｅｓｓａ Ｒｅｓｅａｒｃｈ， Ｉｎｃ． 下痢症治療のための組成物および方法
KR102175201B1 (ko) * 2019-09-06 2020-11-06 (주)아이엠디팜 빌베리 추출물을 유효성분으로 함유하는 감각신경성 난청 예방 또는 치료용 조성물
EP4299059A1 (en) 2022-07-01 2024-01-03 Labelic Analysis, S.L. Composition for the treatment of tinnitus

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103756A (en) * 1999-08-11 2000-08-15 Vitacost Inc. Ocular orally ingested composition for prevention and treatment of individuals
US6524619B2 (en) * 2000-01-27 2003-02-25 Chronorx, Inc. Dosage forms useful for modifying conditions and functions associated with hearing loss and/or tinnitus
JP2002308752A (ja) * 2001-04-06 2002-10-23 Nikko Chemical Co Ltd 皮膚外用剤
DE202004004618U1 (de) * 2004-03-24 2004-05-19 Aiones The Brainpower Company Blaubeerextrakt
WO2005092330A1 (de) * 2004-03-24 2005-10-06 Aiones The Brainpower Company Arzneimittel oder diätetikum zur oralen verabreichung enthaltend blaubeerextrakt sowie antioxidatien und mikronährstoffe
JP2005306882A (ja) * 2005-06-08 2005-11-04 Alan Smith Richard 感情的不安定の治療のための医薬の製造に有用な組成物

Also Published As

Publication number Publication date
CA2646528A1 (en) 2007-09-20
WO2007104566A1 (de) 2007-09-20
EA013457B1 (ru) 2010-04-30
US20090220592A1 (en) 2009-09-03
IL194066A0 (en) 2009-09-22
US20110280972A1 (en) 2011-11-17
DE102006011922A1 (de) 2007-09-20
EA200801890A1 (ru) 2009-04-28
EP1993578A1 (de) 2008-11-26
JP2009529559A (ja) 2009-08-20

Similar Documents

Publication Publication Date Title
US6787164B2 (en) Composition and method for treating the effects of diseases and maladies
TWI406666B (zh) Niu Zhangzhi for the treatment of diseases
WO1995017889A1 (en) Therapeutic composition for hyperparathyroidism of patient subjected to artificial dialysis
US20010044411A1 (en) Composition and method for treating the effects of diseases and maladies
US8557310B2 (en) Composition to retard the onset of symptoms of alzheimer's disease
US20110280972A1 (en) Preparation for the treatment of tinnitus
RU2418601C2 (ru) Средство, обладающее гепатопротекторным, детоксицирующим и регенерирующим действием
TW200930385A (en) Composition with active ingredient combination for the treatment of constipation
US5397573A (en) Laxative compositions
US8021701B1 (en) Composition to retard the onset of symptoms of alzheimer's disease
CA3000918A1 (en) Pharmaceutical compositions containing cannabis, uses thereof and methods for improving sleep quality
KR20150037890A (ko) 암-관련 피로 치료용 조성물
US9226944B2 (en) Herbal preparation for sleep apnea relief
KR20140030360A (ko) 홍삼을 유효성분으로 함유하는 인플루엔자 의사 증상의 예방 및 개선을 위한 조성물
JP5380930B2 (ja) 睡眠改善剤
JP2023519697A (ja) ライノウイルス感染の防止または処置における使用のための酪酸ナトリウム
CN117462642B (zh) 一种治疗腹泻的中药组合物及其制备方法和用途
CN114617916B (zh) 一种枇杷叶提取物及其在康养方面中的应用
JP2003226650A (ja) 医薬用組成物
US20010043959A1 (en) Composition and method for treating the effects of diseases and maladies
JP7074388B1 (ja) 鼻用の外用剤
KR0155976B1 (ko) 항스트레스 의약조성물
Gowing et al. Therapeutic use of cannabis: clarifying the debate
WO2024180572A1 (en) An herbal formulation prs-14 for reducing the effects of pcod, infertility, endometriosis and uterus fibroids
WO2005092330A1 (de) Arzneimittel oder diätetikum zur oralen verabreichung enthaltend blaubeerextrakt sowie antioxidatien und mikronährstoffe

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application